Lv6
1710 积分 2022-02-17 加入
A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis
3天前
已完结
Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice
3天前
已完结
Apprehending Ulcerative Colitis Management With Springing Up Therapeutic Approaches: Can Nanotechnology Play a Nascent Role?
3天前
已完结
Review article: novel oral‐targeted therapies in inflammatory bowel disease
3天前
已完结
The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients?
3天前
已完结
New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance
3天前
已完结
Was ist gesichert in der Therapie chronisch-entzündlicher Darmerkrankungen
3天前
已完结
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
3天前
已完结
Efficacy and Safety of Ustekinumab in Treatment of Ulcerative Colitis: A Systematic Review
3天前
求助中
Pharmacological management of spondyloarthritis associated with inflammatory bowel disease: a systematic review of efficacy, safety, and emerging therapies
3天前
已完结
皖公网安备34019202002308
